News & Views

The Cardiovascular and Renal Benefits of RAASi Therapy

Inhibition of the renin-angiotensin-aldosterone system (RAASi) is recommended in a range of clinical guidelines, both for heart failure (HF)1,2,3 and chronic kidney disease (CKD).4 Medications which inhibit the RAAS include angiotensin-converting enzyme inhibitors (ACE-I), angiotensin receptor blockers (ARBs), angiotensin II receptor/neprilysin inhibitors (ARNI) and mineralocorticoid receptor antagonists (MRAs). But what…

Read more

Date of publication:
September 5, 2018

News & Views

ERA-EDTA 2018: Growing Understanding of the Complexities of Hyperkalaemia

The annual ERA-EDTA conference brings together nephrology experts from around the world, and this, its 55th year, was no different. Here, the COMPACT RENAL team summarise the congress highlights relating to hyperkalaemia (HK), including real-world analysis of the impact of HK and analysis of studies into the potassium binders, patiromer…

Read more

Date of publication:
June 29, 2018

News & Views

Preview of ERA-EDTA 2018: Hyperkalaemia

The 55th annual ERA-EDTA congress is fast approaching, providing a vital opportunity for the sharing of new data, discussion of best practice and collaboration of international colleagues. In Copenhagen this year there will also be a new e-campus area showcasing the educational materials available at COMPACT-RENAL.com, as well as a…

Read more

Date of publication:
May 23, 2018

News & Views

Controversies in Management of RAASi Induced Hyperkalaemia

The benefits of Renin Angiotensin Aldosterone System Inhibitors (RAASi) in cardio-renal protection are well-established, and as such their use is recommended by both heart failure1–3 and chronic kidney disease (CKD)4 association guidelines. These guidelines recommend the highest-tolerated targeted doses of RAASi in order to replicate the positive clinical outcomes from…

Read more

Date of publication:
January 23, 2018

News & Views

ASN Kidney Week 2017: The Impact of Hyperkalemia on RAASi Use and New Data on Novel Potassium Binders

At the American Society of Nephrology’s Kidney Week 2017 congress in New Orleans, results from several studies looking at the prevalence and impact of hyperkalemia were presented, alongside data for new therapies which may allow greater use of renin-angiotensin aldosterone system inhibition (RAASi) in patients with CKD and cardiac disease….

Read more

Date of publication:
December 11, 2017

News & Views

Preview of ASN Kidney Week 2017: Hyperkalemia

The American Society of Nephrology – Kidney Week 2017 (ASN 2017) congress takes place October 31st to November 5th 2017 in New Orleans. In this article, the COMPACT RENAL team has highlighted key sessions and posters relating to hyperkalemia. Note that hyperlinks to symposia will take you to the ASN…

Read more

Date of publication:
November 2, 2017

News & Views

ERA-EDTA 2017 Preview: Hyperkalaemia

ERA-EDTA 2017 is fast approaching and, to help you plan your time at the Congress, the COMPACT RENAL team has put together a preview guide to the posters and presentations relating to hyperkalaemia. For full listings for the conference see the ERA-EDTA Planner. COMPACT RENAL will be in the exhibit…

Read more

Date of publication:
June 2, 2017

News & Views

The Challenge of Chronic Hyperkalemia

Controlling potassium levels in CKD patients requires a complex combination of dietary awareness, medication control and targeted therapy. This article, and the accompanying educational slide pack, outline the issues facing clinicians when managing hyperkalemia, the current treatment options and requirements for future therapies. Hyperkalemia is defined as serum potassium levels…

Read more

Date of publication:
January 12, 2017

News & Views

Preview of ASN Kidney Week 2016: Hyperkalemia

The 2016 ASN congress begins in Chicago next week. In this article, the COMPACT RENAL team has highlighted key sessions and posters relating to hyperkalemia. Note that hyperlinks to symposia will take you to the ASN Kidney Week website, where you will have the option to add sessions to your…

Read more

Date of publication:
November 10, 2016

Login

You are about to leave Compact-Renal.com

Clicking the "Continue" link below will take you to an external website. Compact Renal is not responsible for the contents of any external website. Compact Renal is providing these links to you as a convenience, and the inclusion of any links does not imply endorsement of the linked site by Compact Renal.

Do you wish to continue?

Continue Cancel